Secondary tumours in Sjogren's syndrome

The frequent association of Sjogren's syndrome (SS) with non-Hodgkin's B cell lymphoma (NHL) provides an example of the interplay of systemic autoimmunity and lymphoproliferative diseases, and an opportunity to study the pathogenetic steps of lymphomagenesis. NHL develops in approximately...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Kovács László
Szodoray Péter
Kiss Emese
Dokumentumtípus: Cikk
Megjelent: 2010
Sorozat:AUTOIMMUNITY REVIEWS 9 No. 4
doi:10.1016/j.autrev.2009.07.002

mtmt:1910826
Online Access:http://publicatio.bibl.u-szeged.hu/16597
LEADER 01893nab a2200229 i 4500
001 publ16597
005 20190903090615.0
008 190903s2010 hu o 0|| zxx d
022 |a 1568-9972 
024 7 |a 10.1016/j.autrev.2009.07.002  |2 doi 
024 7 |a 1910826  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Kovács László 
245 1 0 |a Secondary tumours in Sjogren's syndrome  |h [elektronikus dokumentum] /  |c  Kovács László 
260 |c 2010 
300 |a 203-206 
490 0 |a AUTOIMMUNITY REVIEWS  |v 9 No. 4 
520 3 |a The frequent association of Sjogren's syndrome (SS) with non-Hodgkin's B cell lymphoma (NHL) provides an example of the interplay of systemic autoimmunity and lymphoproliferative diseases, and an opportunity to study the pathogenetic steps of lymphomagenesis. NHL develops in approximately 5% of SS patients. Parotidomegaly, lymphadenopathy, inflammatory neuropathy and vasculitis have been found to be predictive of the development of lymphoma. A subsequent NHL is also heralded by the appearance of cryoglobulinaemia and serum or urinary monoclonal proteins. The typical histological type of NHL in SS is a low-grade extranodal marginal zone B cell lymphoma. The authors discuss the proposed key immunopathologic steps of lymphomagenesis in SS in detail. Recent results indicating the pathogenetic role of ectopic germinal centre formation in the involved exocrine glands, the potential importance of an antigen-driven clonal proliferation of autoreactive B-lymphocytes, the proposed role of the B-lymphocyte activating factor (BAFF) and of further cytokines and, finally, the changes of the chemokine milieu at the site of lymphoma development are highlighted. 
700 0 1 |a Szodoray Péter  |e aut 
700 0 1 |a Kiss Emese  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/16597/1/KovacsLAutoimmunRev2010.pdf  |z Dokumentum-elérés